The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...

Two recent studies from Dr. Sita Kugel’s lab at Fred Hutch Cancer Center identify a key biological signature that not only ...

Dr. Hans-Peter Kiem is deputy director of the Translational Science and Therapeutics division at Fred Hutch. His specialty is ...

During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...

But the surge in Chinese pharma is still ringing alarm bells. “China’s rise in biotech is a threat to the United States,” ...

Yamaha Motor Co., Ltd. (Tokyo: 7272) has delivered the CELL HANDLER 2 cell picking and imaging system, which contributes to ...

Frederick R. Appelbaum, MD, recognized for advancing marrow transplantation, talks about the impact of canine research on ...

Renowned American physician‑scientist Frederick R. Appelbaum, MD, discusses the development of bone marrow transplantation as a curative therapy at the 2025 ACVIM Forum ...

When offered the opportunity to participate in clinical trials, patients with breast cancer across racial and ethnic groups ...

A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...

The American Cancer Society (ACS) is projecting there will be more than 2 million new cancer cases in 2025 with an estimated ...

FDA approves tafasitamab with lenalidomide and rituximab, offering a groundbreaking chemotherapy-free treatment for relapsed ...